Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Rheumatoid Arthritis

  Free Subscription


13.06.2022

1 Ann Rheum Dis
3 Arthritis Res Ther
3 Clin Rheumatol
4 J Rheumatol
2 PLoS One
1 Rheumatol Int
1 Scand J Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. COOLES FAH, Tarn J, Lendrem DW, Naamane N, et al
    Interferon-alpha-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming.
    Ann Rheum Dis. 2022 Jun 9. pii: annrheumdis-2022-222370.
    PubMed         Abstract available


    Arthritis Res Ther

  2. SHODA J, Tanaka S, Etori K, Hattori K, et al
    Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the synovium.
    Arthritis Res Ther. 2022;24:134.
    PubMed         Abstract available

  3. SCHMITT C, Brockwell L, Giraudon M, Zucchetto M, et al
    Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study.
    Arthritis Res Ther. 2022;24:133.
    PubMed         Abstract available

  4. BERTSIAS A, Avgoustidis N, Papalopoulos I, Repa A, et al
    Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study.
    Arthritis Res Ther. 2022;24:132.
    PubMed         Abstract available


    Clin Rheumatol

  5. WANG F, Tang J, Li Z, Qi Y, et al
    Oral methotrexate at doses 15-25 mg/week is non-inferior to parenteral regarding efficacy and safety in the treatment of rheumatoid arthritis: a systematic review and meta-analysis.
    Clin Rheumatol. 2022 Jun 7. pii: 10.1007/s10067-022-06221.
    PubMed         Abstract available

  6. WALKER D, Goff I, Robinson S
    Real-world single-centre experience of rheumatoid arthritis patients requiring four or more higher cost drugs: response and duration of treatment.
    Clin Rheumatol. 2022 Jun 7. pii: 10.1007/s10067-022-06232.
    PubMed         Abstract available

  7. QIU J, Lu C, Zhang L, Zhou X, et al
    Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors.
    Clin Rheumatol. 2022 Jun 7. pii: 10.1007/s10067-022-06212.
    PubMed         Abstract available


    J Rheumatol

  8. DARABIAN S, Wade JP, Kur J, Wade SD, et al
    Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience.
    J Rheumatol. 2022;49:558-565.
    PubMed         Abstract available

  9. NASH P
    Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis.
    J Rheumatol. 2022;49.
    PubMed         Abstract available

  10. BESSETTE L, Mysler E, Kinch CD, Kwok K, et al
    Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials.
    J Rheumatol. 2022;49:566-576.
    PubMed         Abstract available

  11. LUBBERTS E, Scher JU, FitzGerald O
    Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis.
    J Rheumatol. 2022;49.
    PubMed         Abstract available


    PLoS One

  12. DESSIE G
    Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa.
    PLoS One. 2022;17:e0269431.
    PubMed         Abstract available

  13. LI Z, Mu Y, Guo C, You X, et al
    Analysis of the saliva metabolic signature in patients with primary Sjogren's syndrome.
    PLoS One. 2022;17:e0269275.
    PubMed         Abstract available


    Rheumatol Int

  14. INGRAM T, Sengupta R, Standage M, Barnett R, et al
    Correlates of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review.
    Rheumatol Int. 2022 Jun 8. pii: 10.1007/s00296-022-05142.
    PubMed         Abstract available


    Scand J Rheumatol

  15. ZHANG K, Jia Y, Wang R, Guo D, et al
    Rheumatoid arthritis and the risk of major cardiometabolic diseases: a Mendelian randomization study.
    Scand J Rheumatol. 2022 Jun 6:1-7. doi: 10.1080/03009742.2022.2070988.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: